Moreover, higher ITSS levels correlate with an elevated Ki-67 labeling index (Ki-67 LI) and ATRX gene wild-type status, both of which are markers of poorer prognosis in IDH-mutant astrocytomas (46). This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).